Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-27 @ 9:23 AM
Study NCT ID:
NCT06275334
Status:
RECRUITING
Last Update Posted:
2024-02-23
First Post:
2024-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dinutuximab Beta at the HUS and the Toulouse Oncopole
Sponsor:
University Hospital, Strasbourg, France
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-11-28
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-01
First Submit QC Date:
None
Study First Post Date:
2024-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-16
Last Update Post Date:
2024-02-23
Last Update Post Date Type:
ACTUAL